Cargando…
2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
BACKGROUND: Influenza-like illnesses (ILI) are common in military populations due to close living and working conditions, physical exertion, and exposure to novel viruses. The PAIVED trial aims to compare the effectiveness of 3 FDA approved influenza vaccines in active-duty military, retiree, and de...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809891/ http://dx.doi.org/10.1093/ofid/ofz360.2477 |
_version_ | 1783462108630876160 |
---|---|
author | Schofield, Christina Richard, Stephanie Colombo, Rhonda Collins, Limone Ganesan, Anuradha Geaney, Casey Lalani, Tahaniyat Markelz, Ana E Maves, Ryan Mende, Katrin Seshadri, Srihari Spooner, Christina Utz, Gregory Warkentien, Tyler Coles, Christian L Burgess, Timothy |
author_facet | Schofield, Christina Richard, Stephanie Colombo, Rhonda Collins, Limone Ganesan, Anuradha Geaney, Casey Lalani, Tahaniyat Markelz, Ana E Maves, Ryan Mende, Katrin Seshadri, Srihari Spooner, Christina Utz, Gregory Warkentien, Tyler Coles, Christian L Burgess, Timothy |
author_sort | Schofield, Christina |
collection | PubMed |
description | BACKGROUND: Influenza-like illnesses (ILI) are common in military populations due to close living and working conditions, physical exertion, and exposure to novel viruses. The PAIVED trial aims to compare the effectiveness of 3 FDA approved influenza vaccines in active-duty military, retiree, and dependent populations, and will also provide information about the burden, impact, and severity of ILI. METHODS: Participants were enrolled in the 2018–2019 influenza season at 5 geographically diverse military facilities. Active duty, non-recruit military personnel, retirees, and dependents were randomized to receive influenza vaccine (egg-based, recombinant, or cell-culture derived) and then completed weekly electronic surveys throughout the influenza season. If a participant reported ILI symptoms during surveillance, 2 in-person visits with study personnel were scheduled for confirmed ILI. Nasal swabs and blood samples were collected for diagnostic and immunologic testing. RESULTS: Among the 852 non-recruit participants enrolled in PAIVED, 25% were active military, 36% retired military, and 39% dependents. Almost half (48%) were female, and 72% were white, 15% African American, 6% Asian, 4% multiple races, and 3% unknown or other race. 788 participants (92%) responded to at least one surveillance questionnaire. Participants reported 407 ILIs (Figure 1), of which 160 met the study case definition. Between 12 and 28% of the participants experienced an ILI during the surveillance period, and 12 people experienced 2 ILIs. Most sites reported a median 2–3 days of fever/feverishness or chills and 3–4 days of reduced activity associated with an ILI episode. No viruses were detected in 58% of nasal swabs, 1 virus in 40%, and 2 viruses in 1% of swabs (Figure 2 for pathogen data). CONCLUSION: During the period under study, ILIs were common with 1 in 6 participants experiencing a confirmed ILI, many of which were 6–8 days in duration. ILIs resulted in reduced activity, although few individuals reported missing work or school, a situation that could result in greater likelihood of transmission to others. Planned analyses will provide additional information about the pathogens responsible for these illnesses and help guide effective prevention policies in these populations. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6809891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68098912019-10-28 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 Schofield, Christina Richard, Stephanie Colombo, Rhonda Collins, Limone Ganesan, Anuradha Geaney, Casey Lalani, Tahaniyat Markelz, Ana E Maves, Ryan Mende, Katrin Seshadri, Srihari Spooner, Christina Utz, Gregory Warkentien, Tyler Coles, Christian L Burgess, Timothy Open Forum Infect Dis Abstracts BACKGROUND: Influenza-like illnesses (ILI) are common in military populations due to close living and working conditions, physical exertion, and exposure to novel viruses. The PAIVED trial aims to compare the effectiveness of 3 FDA approved influenza vaccines in active-duty military, retiree, and dependent populations, and will also provide information about the burden, impact, and severity of ILI. METHODS: Participants were enrolled in the 2018–2019 influenza season at 5 geographically diverse military facilities. Active duty, non-recruit military personnel, retirees, and dependents were randomized to receive influenza vaccine (egg-based, recombinant, or cell-culture derived) and then completed weekly electronic surveys throughout the influenza season. If a participant reported ILI symptoms during surveillance, 2 in-person visits with study personnel were scheduled for confirmed ILI. Nasal swabs and blood samples were collected for diagnostic and immunologic testing. RESULTS: Among the 852 non-recruit participants enrolled in PAIVED, 25% were active military, 36% retired military, and 39% dependents. Almost half (48%) were female, and 72% were white, 15% African American, 6% Asian, 4% multiple races, and 3% unknown or other race. 788 participants (92%) responded to at least one surveillance questionnaire. Participants reported 407 ILIs (Figure 1), of which 160 met the study case definition. Between 12 and 28% of the participants experienced an ILI during the surveillance period, and 12 people experienced 2 ILIs. Most sites reported a median 2–3 days of fever/feverishness or chills and 3–4 days of reduced activity associated with an ILI episode. No viruses were detected in 58% of nasal swabs, 1 virus in 40%, and 2 viruses in 1% of swabs (Figure 2 for pathogen data). CONCLUSION: During the period under study, ILIs were common with 1 in 6 participants experiencing a confirmed ILI, many of which were 6–8 days in duration. ILIs resulted in reduced activity, although few individuals reported missing work or school, a situation that could result in greater likelihood of transmission to others. Planned analyses will provide additional information about the pathogens responsible for these illnesses and help guide effective prevention policies in these populations. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809891/ http://dx.doi.org/10.1093/ofid/ofz360.2477 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Schofield, Christina Richard, Stephanie Colombo, Rhonda Collins, Limone Ganesan, Anuradha Geaney, Casey Lalani, Tahaniyat Markelz, Ana E Maves, Ryan Mende, Katrin Seshadri, Srihari Spooner, Christina Utz, Gregory Warkentien, Tyler Coles, Christian L Burgess, Timothy 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 |
title | 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 |
title_full | 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 |
title_fullStr | 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 |
title_full_unstemmed | 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 |
title_short | 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 |
title_sort | 2800. pragmatic assessment of influenza vaccine effectiveness in the dod (paived): influenza-like-illness rates in year 1 |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809891/ http://dx.doi.org/10.1093/ofid/ofz360.2477 |
work_keys_str_mv | AT schofieldchristina 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT richardstephanie 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT colomborhonda 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT collinslimone 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT ganesananuradha 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT geaneycasey 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT lalanitahaniyat 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT markelzanae 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT mavesryan 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT mendekatrin 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT seshadrisrihari 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT spoonerchristina 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT utzgregory 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT warkentientyler 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT coleschristianl 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 AT burgesstimothy 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1 |